In the last 12 months, insiders at REGENXBIO Inc. ($RGNX) filed 168 transactions with the SEC: 0 open-market purchases totaling $0 and 27 sales totaling $4,264,075. Net insider sentiment: net selling.
REGENXBIO Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Mills Kenneth T. (Not found) — 24 transactions totaling $6,834,890
- Mills Kenneth T. (President and CEO) — 19 transactions totaling $2,371,034
- PAKOLA STEVE (Chief Medical Officer) — 17 transactions totaling $1,662,375
- Simpson Curran (Chief Executive Officer) — 15 transactions totaling $961,261
- KARABELAS ARGERIS N (Not found) — 24 transactions totaling $923,094
View all SEC Filings for REGENXBIO Inc. (RGNX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | PAKOLA STEVE | Chief Medical Officer | S | Common Stock | 5124 | $10.35 | 247,926.0000 | 51,689,000 | 2.02% | 0.01% |
| Feb. 1, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | F | Common Stock | 4700 | $11.16 | 210,667.0000 | 51,689,000 | 2.18% | 0.01% |
| Feb. 1, 2026 | PAKOLA STEVE | Chief Medical Officer | F | Common Stock | 5267 | $11.16 | 253,050.0000 | 51,689,000 | 2.04% | 0.01% |
| Jan. 27, 2026 | Mills Kenneth T. | Not found | M | Common Stock | 225000 | $13.09 | 707,871.0000 | 51,689,000 | 46.60% | 0.44% |
| Jan. 27, 2026 | Mills Kenneth T. | Not found | F | Common Stock | 221753 | $13.41 | 486,118.0000 | 51,689,000 | 31.33% | 0.43% |
| Jan. 27, 2026 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 51,689,000 | 50.00% | 0.44% |
| Jan. 6, 2026 | Malzahn Craig | Chief Technology Officer | A | Common Stock | 65847 | $0.00 | 82,194.0000 | 51,689,000 | 402.81% | 0.13% |
| Jan. 6, 2026 | Malzahn Craig | Chief Technology Officer | A | Stock Options (Right to buy) | 35402 | $0.00 | 35,402.0000 | 51,689,000 | 9999.99% | 0.07% |
| Jan. 6, 2026 | PAKOLA STEVE | Chief Medical Officer | A | Common Stock | 65847 | $0.00 | 258,317.0000 | 51,689,000 | 34.21% | 0.13% |
| Jan. 6, 2026 | PAKOLA STEVE | Chief Medical Officer | A | Stock Options (Right to buy) | 35402 | $0.00 | 35,402.0000 | 51,689,000 | 9999.99% | 0.07% |
| Jan. 6, 2026 | Simpson Curran | Chief Executive Officer | A | Common Stock | 144864 | $0.00 | 342,467.0000 | 51,689,000 | 73.31% | 0.28% |
| Jan. 6, 2026 | Simpson Curran | Chief Executive Officer | A | Stock Options (Right to buy) | 233651 | $0.00 | 233,651.0000 | 51,689,000 | 9999.99% | 0.45% |
| Jan. 6, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | A | Common Stock | 73749 | $0.00 | 215,367.0000 | 51,689,000 | 52.08% | 0.14% |
| Jan. 6, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | A | Stock Options (Right to buy) | 39650 | $0.00 | 39,650.0000 | 51,689,000 | 9999.99% | 0.08% |
| Jan. 6, 2026 | Chan Mitchell | Chief Financial Officer | A | Common Stock | 73749 | $0.00 | 127,717.0000 | 51,689,000 | 136.65% | 0.14% |
| Jan. 6, 2026 | Chan Mitchell | Chief Financial Officer | A | Stock Options (Right to buy) | 39650 | $0.00 | 39,650.0000 | 51,689,000 | 9999.99% | 0.08% |
| Jan. 2, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | F | Common Stock | 9793 | $14.40 | 141,618.0000 | 51,689,000 | 6.47% | 0.02% |
| Jan. 2, 2026 | Simpson Curran | Chief Executive Officer | F | Common Stock | 18559 | $14.40 | 197,603.0000 | 51,689,000 | 8.59% | 0.04% |
| Jan. 2, 2026 | Malzahn Craig | Chief Technology Officer | F | Common Stock | 1238 | $14.40 | 16,347.0000 | 51,689,000 | 7.04% | 0.00% |
| Jan. 2, 2026 | PAKOLA STEVE | Chief Medical Officer | F | Common Stock | 18247 | $14.40 | 192,470.0000 | 51,689,000 | 8.66% | 0.04% |
| Oct. 9, 2025 | Simpson Curran | Chief Executive Officer | S | Common Stock | 20811 | $12.62 | 216,162.0000 | 51,689,000 | 8.78% | 0.04% |
| Sept. 29, 2025 | Simpson Curran | Chief Executive Officer | S | Common Stock | 7624 | $10.03 | 236,973.0000 | 49,509,000 | 3.12% | 0.02% |
| Sept. 10, 2025 | Simpson Curran | Chief Executive Officer | S | Common Stock | 7734 | $10.02 | 244,597.0000 | 49,509,000 | 3.07% | 0.02% |
| Sept. 1, 2025 | Malzahn Craig | Chief Technology Officer | F | Common Stock | 234 | $8.93 | 17,585.0000 | 49,509,000 | 1.31% | 0.00% |
| Sept. 1, 2025 | Chan Mitchell | Chief Financial Officer | F | Common Stock | 4901 | $8.93 | 53,968.0000 | 49,509,000 | 8.33% | 0.01% |
| Aug. 1, 2025 | Christmas Patrick J. | Chief Strategy & Legal Officer | F | Common Stock | 4699 | $8.19 | 151,411.0000 | 49,509,000 | 3.01% | 0.01% |
| July 1, 2025 | Simpson Curran | Chief Executive Officer | F | Common Stock | 4701 | $8.23 | 252,331.0000 | 49,509,000 | 1.83% | 0.01% |
| May 30, 2025 | Fox Allan M. | Not found | A | Common Stock | 7768 | $0.00 | 2,901,520.0000 | 49,509,000 | 0.27% | 0.02% |
| May 30, 2025 | Fox Allan M. | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | Zachary Jennifer | Not found | A | Common Stock | 7768 | $0.00 | 22,064.0000 | 49,509,000 | 54.34% | 0.02% |
| May 30, 2025 | Zachary Jennifer | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | Tasse Daniel | Not found | A | Common Stock | 7768 | $0.00 | 19,054.0000 | 49,509,000 | 68.83% | 0.02% |
| May 30, 2025 | Tasse Daniel | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | STUMP DAVID C | Not found | A | Common Stock | 7768 | $0.00 | 19,054.0000 | 49,509,000 | 68.83% | 0.02% |
| May 30, 2025 | STUMP DAVID C | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | MIGAUSKY GEORGE V | Not found | A | Common Stock | 7768 | $0.00 | 19,054.0000 | 49,509,000 | 68.83% | 0.02% |
| May 30, 2025 | Bennett Jean | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | Bennett Jean | Not found | A | Common Stock | 7768 | $0.00 | 19,054.0000 | 49,509,000 | 68.83% | 0.02% |
| May 30, 2025 | KARABELAS ARGERIS N | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | Glucksmann Alexandra | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | KARABELAS ARGERIS N | Not found | A | Common Stock | 7768 | $0.00 | 19,054.0000 | 49,509,000 | 68.83% | 0.02% |
| May 30, 2025 | Glucksmann Alexandra | Not found | A | Common Stock | 7768 | $0.00 | 19,054.0000 | 49,509,000 | 68.83% | 0.02% |
| May 30, 2025 | MIGAUSKY GEORGE V | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 30, 2025 | Mills Kenneth T. | Not found | A | Common Stock | 7768 | $0.00 | 482,871.0000 | 49,509,000 | 1.64% | 0.02% |
| May 30, 2025 | Mills Kenneth T. | Not found | A | Stock Options (Right to Buy) | 39815 | $0.00 | 39,815.0000 | 49,509,000 | 9999.99% | 0.08% |
| May 12, 2025 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 20602 | $0.00 | 0.0000 | 49,509,000 | 100.00% | 0.04% |
| May 12, 2025 | Mills Kenneth T. | Not found | S | Common Stock | 20602 | $7.91 | 475,103.0000 | 49,509,000 | 4.16% | 0.04% |
| May 12, 2025 | Mills Kenneth T. | Not found | M | Common Stock | 20602 | $3.76 | 495,705.0000 | 49,509,000 | 4.34% | 0.04% |
| Feb. 1, 2025 | Danos Olivier | Chief Scientific Officer | F | Common Stock | 5452 | $8.07 | 226,348.0000 | 49,509,000 | 2.35% | 0.01% |
| Feb. 1, 2025 | PAKOLA STEVE | Chief Medical Officer | F | Common Stock | 5263 | $8.07 | 210,717.0000 | 49,509,000 | 2.44% | 0.01% |
| Feb. 1, 2025 | Christmas Patrick J. | Chief Legal Officer | F | Common Stock | 4700 | $8.07 | 156,110.0000 | 49,509,000 | 2.92% | 0.01% |
| March 27, 2025 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 30752 | $0.00 | 20,602.0000 | 49,509,000 | 59.88% | 0.06% |
| March 27, 2025 | Mills Kenneth T. | Not found | M | Common Stock | 30752 | $3.76 | 475,103.0000 | 49,509,000 | 6.92% | 0.06% |
| Jan. 2, 2025 | Simpson Curran | Chief Executive Officer | A | Stock Options (Right to buy) | 478606 | $0.00 | 478,606.0000 | 49,509,000 | 9999.99% | 0.97% |
| Jan. 2, 2025 | Simpson Curran | Chief Executive Officer | A | Stock Options (Right to buy) | 476606 | $0.00 | 476,606.0000 | 49,509,000 | 9999.99% | 0.96% |
| Jan. 2, 2025 | PAKOLA STEVE | Chief Medical Officer | F | Common Stock | 13891 | $7.73 | 151,687.0000 | 49,509,000 | 8.39% | 0.03% |
| Jan. 2, 2025 | PAKOLA STEVE | Chief Medical Officer | A | Common Stock | 64293 | $0.00 | 215,980.0000 | 49,509,000 | 42.39% | 0.13% |
| Jan. 2, 2025 | PAKOLA STEVE | Chief Medical Officer | A | Stock Options (Right to buy) | 103698 | $0.00 | 103,698.0000 | 49,509,000 | 9999.99% | 0.21% |
| Jan. 2, 2025 | Danos Olivier | Chief Scientific Officer | F | Common Stock | 12630 | $7.73 | 172,453.0000 | 49,509,000 | 6.82% | 0.03% |
| Jan. 2, 2025 | Danos Olivier | Chief Scientific Officer | A | Common Stock | 59347 | $0.00 | 231,800.0000 | 49,509,000 | 34.41% | 0.12% |
| Jan. 2, 2025 | Danos Olivier | Chief Scientific Officer | A | Stock Options (Right to buy) | 95721 | $0.00 | 95,721.0000 | 49,509,000 | 9999.99% | 0.19% |
| Jan. 2, 2025 | Chan Mitchell | Chief Financial Officer | A | Stock Options (Right to buy) | 62547 | $0.00 | 62,547.0000 | 49,509,000 | 9999.99% | 0.13% |
| Jan. 2, 2025 | Christmas Patrick J. | Chief Legal Officer | F | Common Stock | 11395 | $7.73 | 160,810.0000 | 49,509,000 | 6.62% | 0.02% |
| Jan. 2, 2025 | Christmas Patrick J. | Chief Legal Officer | A | Stock Options (Right to buy) | 223350 | $0.00 | 223,350.0000 | 49,509,000 | 9999.99% | 0.45% |
| Jan. 2, 2025 | Simpson Curran | Chief Executive Officer | F | Common Stock | 11917 | $7.73 | 158,120.0000 | 49,509,000 | 7.01% | 0.02% |
| Jan. 2, 2025 | Simpson Curran | Chief Executive Officer | A | Common Stock | 98912 | $0.00 | 257,032.0000 | 49,509,000 | 62.56% | 0.20% |
| Oct. 1, 2024 | KARABELAS ARGERIS N | Not found | M | Common Stock | 10000 | $3.76 | 21,286.0000 | 50,800,000 | 88.61% | 0.02% |
| Oct. 1, 2024 | KARABELAS ARGERIS N | Not found | M | Stock Options (Right to Buy) | 10000 | $0.00 | 0.0000 | 50,800,000 | 100.00% | 0.02% |
| Oct. 1, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 10000 | $10.11 | 11,286.0000 | 50,800,000 | 46.98% | 0.02% |
| Sept. 16, 2024 | Chan Mitchell | Chief Financial Officer | A | Stock Options (Right to buy) | 289362 | $0.00 | 289,362.0000 | 43,734,000 | 9999.99% | 0.66% |
| Sept. 16, 2024 | Chan Mitchell | Chief Financial Officer | A | Common Stock | 58869 | $0.00 | 58,869.0000 | 43,734,000 | 9999.99% | 0.13% |
| Sept. 3, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 9300 | $11.50 | 11,986.0000 | 43,734,000 | 43.69% | 0.02% |
| Sept. 3, 2024 | KARABELAS ARGERIS N | Not found | M | Common Stock | 10000 | $3.76 | 21,286.0000 | 43,734,000 | 88.61% | 0.02% |
| Sept. 3, 2024 | KARABELAS ARGERIS N | Not found | M | Stock Options (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 43,734,000 | 50.00% | 0.02% |
| Sept. 3, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 700 | $12.34 | 11,286.0000 | 43,734,000 | 5.84% | 0.00% |
| Aug. 8, 2024 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 36316 | $0.00 | 0.0000 | 43,734,000 | 100.00% | 0.08% |
| Aug. 8, 2024 | Mills Kenneth T. | Not found | M | Common Stock | 36316 | $0.85 | 444,351.0000 | 43,734,000 | 8.90% | 0.08% |
| June 28, 2024 | Danos Olivier | Chief Scientific Officer | A | Common Stock | 1363 | $9.95 | 126,216.0000 | 43,734,000 | 1.09% | 0.00% |
| Aug. 1, 2024 | PAKOLA STEVE | Chief Medical Officer | A | Common Stock | 58386 | $0.00 | 165,578.0000 | 43,734,000 | 54.47% | 0.13% |
| Aug. 1, 2024 | Christmas Patrick J. | Chief Legal Officer | A | Common Stock | 56446 | $0.00 | 172,205.0000 | 43,734,000 | 48.76% | 0.13% |
| Aug. 1, 2024 | KARABELAS ARGERIS N | Not found | M | Common Stock | 10000 | $3.76 | 21,286.0000 | 43,734,000 | 88.61% | 0.02% |
| Aug. 1, 2024 | KARABELAS ARGERIS N | Not found | M | Common Stock | 100 | $12.74 | 21,386.0000 | 43,734,000 | 0.47% | 0.00% |
| Aug. 1, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 9600 | $13.45 | 11,786.0000 | 43,734,000 | 44.89% | 0.02% |
| Aug. 1, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 400 | $14.59 | 11,386.0000 | 43,734,000 | 3.39% | 0.00% |
| Aug. 1, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 100 | $15.00 | 11,286.0000 | 43,734,000 | 0.88% | 0.00% |
| Aug. 1, 2024 | KARABELAS ARGERIS N | Not found | M | Stock Options (Right to Buy) | 100 | $0.00 | 1,400.0000 | 43,734,000 | 6.67% | 0.00% |
| Aug. 1, 2024 | KARABELAS ARGERIS N | Not found | M | Stock Options (Right to Buy) | 10000 | $0.00 | 20,000.0000 | 43,734,000 | 33.33% | 0.02% |
| Aug. 1, 2024 | Simpson Curran | Chief Executive Officer | S | Common Stock | 100 | $15.00 | 170,037.0000 | 43,734,000 | 0.06% | 0.00% |
| Aug. 1, 2024 | Danos Olivier | Chief Scientific Officer | A | Common Stock | 58867 | $0.00 | 185,083.0000 | 43,734,000 | 46.64% | 0.13% |
| July 29, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 11000 | $15.05 | 11,286.0000 | 43,734,000 | 49.36% | 0.03% |
| July 29, 2024 | Simpson Curran | Chief Executive Officer | S | Common Stock | 9648 | $15.04 | 170,137.0000 | 43,734,000 | 5.37% | 0.02% |
| July 29, 2024 | KARABELAS ARGERIS N | Not found | M | Common Stock | 11000 | $12.74 | 22,286.0000 | 43,734,000 | 97.47% | 0.03% |
| July 29, 2024 | KARABELAS ARGERIS N | Not found | M | Stock Options (Right to Buy) | 11000 | $0.00 | 1,500.0000 | 43,734,000 | 88.00% | 0.03% |
| July 24, 2024 | Mills Kenneth T. | Not found | S | Common Stock | 12221 | $13.78 | 408,035.0000 | 43,734,000 | 2.91% | 0.03% |
| July 24, 2024 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 12221 | $0.00 | 66,723.0000 | 43,734,000 | 15.48% | 0.03% |
| July 24, 2024 | Mills Kenneth T. | Not found | M | Common Stock | 12221 | $3.76 | 420,256.0000 | 43,734,000 | 3.00% | 0.03% |
| July 25, 2024 | Mills Kenneth T. | Not found | S | Common Stock | 15369 | $13.96 | 408,035.0000 | 43,734,000 | 3.63% | 0.04% |
| July 25, 2024 | Mills Kenneth T. | Not found | M | Common Stock | 15369 | $3.76 | 423,404.0000 | 43,734,000 | 3.77% | 0.04% |
| July 25, 2024 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 15369 | $0.00 | 51,354.0000 | 43,734,000 | 23.03% | 0.04% |
| July 17, 2024 | Mills Kenneth T. | Not found | M | Common Stock | 2210 | $3.76 | 410,245.0000 | 43,734,000 | 0.54% | 0.01% |
| July 16, 2024 | Mills Kenneth T. | Not found | M | Common Stock | 200 | $3.76 | 408,235.0000 | 43,734,000 | 0.05% | 0.00% |
| July 17, 2024 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 2210 | $0.00 | 78,944.0000 | 43,734,000 | 2.72% | 0.01% |
| July 16, 2024 | Mills Kenneth T. | Not found | M | Stock Options (Right to Buy) | 200 | $0.00 | 81,154.0000 | 43,734,000 | 0.25% | 0.00% |
| July 17, 2024 | Mills Kenneth T. | Not found | S | Common Stock | 2210 | $13.77 | 408,035.0000 | 43,734,000 | 0.54% | 0.01% |
| July 16, 2024 | Mills Kenneth T. | Not found | S | Common Stock | 200 | $13.76 | 408,035.0000 | 43,734,000 | 0.05% | 0.00% |
| July 1, 2024 | KARABELAS ARGERIS N | Not found | M | Common Stock | 10000 | $3.76 | 21,286.0000 | 43,734,000 | 88.61% | 0.02% |
| July 1, 2024 | Simpson Curran | Chief Executive Officer | A | Common Stock | 56458 | $0.00 | 179,785.0000 | 43,734,000 | 45.78% | 0.13% |
| July 1, 2024 | Simpson Curran | Chief Executive Officer | A | Stock Options (Right to Buy) | 272189 | $0.00 | 272,189.0000 | 43,734,000 | 9999.99% | 0.62% |
| July 1, 2024 | KARABELAS ARGERIS N | Not found | S | Common Stock | 10000 | $11.27 | 11,286.0000 | 43,734,000 | 46.98% | 0.02% |
| July 1, 2024 | KARABELAS ARGERIS N | Not found | M | Stock Options (Right to Buy) | 10000 | $0.00 | 30,000.0000 | 43,734,000 | 25.00% | 0.02% |
| May 31, 2024 | STUMP DAVID C | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | Zachary Jennifer | Not found | A | Common Stock | 4790 | $0.00 | 14,296.0000 | 43,734,000 | 50.39% | 0.01% |
| May 31, 2024 | Zachary Jennifer | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | MIGAUSKY GEORGE V | Not found | A | Common Stock | 4790 | $0.00 | 11,286.0000 | 43,734,000 | 73.74% | 0.01% |
| May 31, 2024 | MIGAUSKY GEORGE V | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | KARABELAS ARGERIS N | Not found | A | Common Stock | 4790 | $0.00 | 11,286.0000 | 43,734,000 | 73.74% | 0.01% |
| May 31, 2024 | KARABELAS ARGERIS N | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | Glucksmann Alexandra | Not found | A | Common Stock | 4790 | $0.00 | 11,286.0000 | 43,734,000 | 73.74% | 0.01% |
| May 31, 2024 | Glucksmann Alexandra | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | Bennett Jean | Not found | A | Common Stock | 4790 | $0.00 | 11,286.0000 | 43,734,000 | 73.74% | 0.01% |
| May 31, 2024 | Bennett Jean | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | Fox Allan M. | Not found | A | Common Stock | 4790 | $0.00 | 2,893,752.0000 | 43,734,000 | 0.17% | 0.01% |
| May 31, 2024 | Fox Allan M. | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | Tasse Daniel | Not found | A | Common Stock | 4790 | $0.00 | 11,286.0000 | 43,734,000 | 73.74% | 0.01% |
| May 31, 2024 | Tasse Daniel | Not found | A | Stock Options (Right to Buy) | 24454 | $0.00 | 24,454.0000 | 43,734,000 | 9999.99% | 0.06% |
| May 31, 2024 | STUMP DAVID C | Not found | A | Common Stock | 4790 | $0.00 | 11,286.0000 | 43,734,000 | 73.74% | 0.01% |
| May 14, 2024 | Mills Kenneth T. | President and CEO | S | Common Stock | 15000 | $15.81 | 408,035.0000 | 43,734,000 | 3.55% | 0.03% |
| May 14, 2024 | Mills Kenneth T. | President and CEO | M | Common Stock | 15000 | $3.76 | 423,035.0000 | 43,734,000 | 3.68% | 0.03% |
| May 14, 2024 | Mills Kenneth T. | President and CEO | M | Stock Options (Right to Buy) | 15000 | $0.00 | 81,354.0000 | 43,734,000 | 15.57% | 0.03% |
| April 15, 2024 | Mills Kenneth T. | President and CEO | S | Common Stock | 15000 | $18.19 | 408,035.0000 | 43,734,000 | 3.55% | 0.03% |
| April 15, 2024 | Mills Kenneth T. | President and CEO | M | Common Stock | 15000 | $3.76 | 423,035.0000 | 43,734,000 | 3.68% | 0.03% |
| April 15, 2024 | Mills Kenneth T. | President and CEO | M | Stock Options (Right to Buy) | 15000 | $0.00 | 96,354.0000 | 43,734,000 | 13.47% | 0.03% |
| March 19, 2024 | Vasista Vittal | Chief Financial Officer | M | Common Stock | 20041 | $3.76 | 246,534.0000 | 43,734,000 | 8.85% | 0.05% |
| March 19, 2024 | Vasista Vittal | Chief Financial Officer | M | Employee Stock Option (Right to Buy) | 20041 | $0.00 | 0.0000 | 43,734,000 | 100.00% | 0.05% |
| March 14, 2024 | Mills Kenneth T. | President and CEO | S | Common Stock | 15000 | $21.86 | 408,035.0000 | 43,734,000 | 3.55% | 0.03% |
| March 14, 2024 | Mills Kenneth T. | President and CEO | M | Common Stock | 15000 | $3.76 | 423,035.0000 | 43,734,000 | 3.68% | 0.03% |
| March 14, 2024 | Mills Kenneth T. | President and CEO | M | Stock Options (Right to Buy) | 15000 | $0.00 | 111,354.0000 | 43,734,000 | 11.87% | 0.03% |
| March 5, 2024 | PAKOLA STEVE | Chief Medical Officer | S | Common Stock | 12878 | $28.36 | 107,192.0000 | 43,734,000 | 10.73% | 0.03% |
| March 5, 2024 | PAKOLA STEVE | Chief Medical Officer | M | Stock Options (Right to Buy) | 12878 | $0.00 | 31,277.0000 | 43,734,000 | 29.17% | 0.03% |
| March 5, 2024 | PAKOLA STEVE | Chief Medical Officer | M | Common Stock | 12878 | $22.25 | 120,070.0000 | 43,734,000 | 12.01% | 0.03% |
| Feb. 14, 2024 | Mills Kenneth T. | President and CEO | M | Common Stock | 15000 | $3.76 | 423,035.0000 | 43,734,000 | 3.68% | 0.03% |
| Feb. 14, 2024 | Mills Kenneth T. | President and CEO | M | Stock Options (Right to Buy) | 15000 | $0.00 | 126,354.0000 | 43,734,000 | 10.61% | 0.03% |
| Feb. 14, 2024 | Mills Kenneth T. | President and CEO | S | Common Stock | 10348 | $16.88 | 408,035.0000 | 43,734,000 | 2.47% | 0.02% |
| Feb. 14, 2024 | Mills Kenneth T. | President and CEO | S | Common Stock | 4652 | $16.47 | 418,383.0000 | 43,734,000 | 1.10% | 0.01% |
| Jan. 16, 2024 | Mills Kenneth T. | President and CEO | S | Common Stock | 45000 | $15.18 | 408,035.0000 | 43,734,000 | 9.93% | 0.10% |
| Jan. 16, 2024 | Mills Kenneth T. | President and CEO | M | Common Stock | 45000 | $3.76 | 453,035.0000 | 43,734,000 | 11.03% | 0.10% |
| Jan. 16, 2024 | Mills Kenneth T. | President and CEO | M | Stock Options (Right to Buy) | 45000 | $0.00 | 141,354.0000 | 43,734,000 | 24.15% | 0.10% |
| Jan. 2, 2024 | Vasista Vittal | Chief Financial Officer | A | Common Stock | 16026 | $0.00 | 226,493.0000 | 43,734,000 | 7.61% | 0.04% |
| Jan. 2, 2024 | Vasista Vittal | Chief Financial Officer | F | Common Stock | 4534 | $17.95 | 210,467.0000 | 43,734,000 | 2.11% | 0.01% |
| Jan. 2, 2024 | Danos Olivier | Chief Scientific Officer | A | Stock Options (Right to buy) | 61050 | $0.00 | 61,050.0000 | 43,734,000 | 9999.99% | 0.14% |
| Jan. 2, 2024 | Danos Olivier | Chief Scientific Officer | A | Common Stock | 38462 | $0.00 | 124,853.0000 | 43,734,000 | 44.52% | 0.09% |
| Jan. 2, 2024 | Danos Olivier | Chief Scientific Officer | F | Common Stock | 8410 | $17.95 | 86,391.0000 | 43,734,000 | 8.87% | 0.02% |
| June 30, 2023 | Danos Olivier | Chief Scientific Officer | A | Common Stock | 1123 | $16.99 | 94,801.0000 | 43,152,000 | 1.20% | 0.00% |
| June 30, 2022 | Danos Olivier | Chief Scientific Officer | A | Common Stock | 728 | $21.00 | 93,678.0000 | 0 | 0.78% | 0.00% |
| Jan. 2, 2024 | PAKOLA STEVE | Chief Medical Officer | A | Stock Options (Right to buy) | 50875 | $0.00 | 50,875.0000 | 43,734,000 | 9999.99% | 0.12% |
| Jan. 3, 2024 | PAKOLA STEVE | Chief Medical Officer | S | Common Stock | 17237 | $17.39 | 107,192.0000 | 43,734,000 | 13.85% | 0.04% |
| Jan. 2, 2024 | PAKOLA STEVE | Chief Medical Officer | A | Common Stock | 32051 | $0.00 | 124,429.0000 | 43,734,000 | 34.70% | 0.07% |
| Jan. 2, 2024 | PAKOLA STEVE | Chief Medical Officer | F | Common Stock | 10385 | $17.95 | 92,378.0000 | 43,734,000 | 10.11% | 0.02% |
| Jan. 2, 2024 | Simpson Curran | Chief Oper. & Tech. Officer | A | Stock Options (Right to buy) | 61050 | $0.00 | 61,050.0000 | 43,734,000 | 9999.99% | 0.14% |
| Jan. 2, 2024 | Simpson Curran | Chief Oper. & Tech. Officer | A | Common Stock | 38462 | $0.00 | 123,327.0000 | 43,734,000 | 45.32% | 0.09% |
| Jan. 2, 2024 | Simpson Curran | Chief Oper. & Tech. Officer | F | Common Stock | 8120 | $17.95 | 84,865.0000 | 43,734,000 | 8.73% | 0.02% |
| Jan. 2, 2024 | Christmas Patrick J. | Chief Legal Officer | A | Stock Options (Right to buy) | 54945 | $0.00 | 54,945.0000 | 43,734,000 | 9999.99% | 0.13% |
| Jan. 2, 2024 | Christmas Patrick J. | Chief Legal Officer | A | Common Stock | 34615 | $0.00 | 115,759.0000 | 43,734,000 | 42.66% | 0.08% |
| Jan. 2, 2024 | Christmas Patrick J. | Chief Legal Officer | F | Common Stock | 7893 | $17.95 | 81,144.0000 | 43,734,000 | 8.86% | 0.02% |
| Jan. 2, 2024 | Mills Kenneth T. | President and CEO | A | Common Stock | 64103 | $0.00 | 408,035.0000 | 43,734,000 | 18.64% | 0.15% |
| Jan. 2, 2024 | Mills Kenneth T. | President and CEO | A | Stock Options (Right to buy) | 305250 | $0.00 | 305,250.0000 | 43,734,000 | 9999.99% | 0.70% |
| Jan. 2, 2024 | Mills Kenneth T. | President and CEO | F | Common Stock | 11357 | $17.95 | 343,932.0000 | 43,734,000 | 3.20% | 0.03% |
| Jan. 2, 2024 | Vasista Vittal | Chief Financial Officer | A | Stock Options (Right to buy) | 76313 | $0.00 | 76,313.0000 | 43,734,000 | 9999.99% | 0.17% |